Muscle Spasms Archives - Page 8 of 8 - MPR

Muscle Spasms

GABLOFEN (baclofen) 50mcg/mL, 500mcg/mL, 2,000mcg/mL for intrathecal injection by CNS Therapeutics

Gablofen approved for severe spasticity

The FDA has approved Gablofen (baclofen for intrathecal injection, from CNS Therapeutics), a centrally active muscle relaxant, for the management of severe spasticity.

Xeomin available for cervical dystonia and blepharospasm

Merz Pharmaceuticals has launched Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naïve and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.

Xeomin approved for cervical dystonia and blepharospasm

Merz Pharmaceuticals announced that the FDA has approved Xeomin (incobotulinumtoxinA) for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naïve and previously treated patients and blepharospasm in adults previously treated with onabotulinumtoxinA.

FDA Video: Muscle Injury from High Doses of Zocor

FDA is informing healthcare professionals that a preliminary review of a large clinical trial shows an increased risk of muscle injury in patients taking the highest dose of the statin drug simvastatin. Simvastatin is sold as Zocor.